Genmab A/S announced that Orbis Investment Management Limited, as of April 13, 2026, controls voting rights to 3,114,318 shares, representing 4.85% of the company's share capital and voting rights.
Key takeaways
Orbis Investment Management Limited reported a shareholding of 3,114,318 shares in Genmab A/S, equivalent to 4.8471% of voting rights.
The notification indicates a decrease from a previous reported voting rights position of 5.0141%.
The holding consists solely of direct shareholdings with no financial instruments or similar economic effects reported.
The notification was made under Section 30 of the Danish Capital Markets Act, triggered by crossing a reporting threshold.
Orbis Investment Management Limited acts as an investment manager with investment discretion and voting control over the shares held by certain funds.